Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
AstraZeneca PLC (NYSE: AZN)
AZN Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
15%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
NOT AVAILABLE
AZN Stock Analysis
AZN
PE Ratio:
26.5
AZN
PEG Ratio:
2
AZN
Forward EPS Growth (12 month):
13.00%
AZN
PS Ratio:
4.5
AZN
PSG Ratio:
0.7
AZN
Forward Revenue Growth (12 month):
6.50%
AZN Articles
No data was found